Selpercatinib
What is Selpercatinib Selpercatinib is a kinase inhibitor that targets wild-type RET and multiple mutated RET isoforms. It is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer who require …